The manufacturer of the antifungal medication Mycamine has settled a whistleblower lawsuit in Philadelphia for $7.3 million.
Under terms of the settlement with the U.S. Department of Justice, Astellas Pharma US Inc., agreed to pay $4.2 million to the federal government and $3.1 million to states that paid for the drug through Medicaid. More than $700,000 of the settlement amount will be paid to Frank Smith, a sales representative who blew the whistle on the company. The federal False Claims Act
Disclaimer - Ross Feller Casey, LLP provides legal advice only after an attorney-client relationship is formed. Our website is an introduction to the firm and does not create a relationship between our attorneys and clients. An attorney-client relationship is formed only after a written agreement is signed by the client and the firm. Because every case is unique, the description of awards and summary of cases successfully handled are not intended to imply or guarantee that same success in other cases. Ross Feller Casey, LLP represents catastrophically injured persons and their families in injury and wrongful death cases, providing legal representation in Pennsylvania and New Jersey.